![Transcriptomics in tumor and normal lung tissues identify early-stage NSCLC patients with high risk of post-surgery recurrence who may benefit from adjuvant therapies Transcriptomics in tumor and normal lung tissues identify early-stage NSCLC patients with high risk of post-surgery recurrence who may benefit from adjuvant therapies logotype](http://winconsortium.org/img/_people/2022-09-16_%288%29.png)
News
![Transcriptomics in tumor and normal lung tissues identify early-stage NSCLC patients with high risk of post-surgery recurrence who may benefit from adjuvant therapies Transcriptomics in tumor and normal lung tissues identify early-stage NSCLC patients with high risk of post-surgery recurrence who may benefit from adjuvant therapies logotype](http://winconsortium.org/img/_people/2022-09-16_%288%29.png)
![InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma logotype](http://winconsortium.org/img/_people/Genome.png)
InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma
Posted: Monday, June 06, 2022
![SPRING Phase I trial results published in Cancer Medicine, Wiley SPRING Phase I trial results published in Cancer Medicine, Wiley logotype](http://winconsortium.org/img/_people/cm_%284%29.png)
SPRING Phase I trial results published in Cancer Medicine, Wiley
Posted: Monday, March 28, 2022
![JIPO and WIN Join Forces to Promote Immunotherapy and Precision Oncology in 2022 JIPO and WIN Join Forces to Promote Immunotherapy and Precision Oncology in 2022 logotype](http://winconsortium.org/img/_people/JIPO-WIN_%283%29.png)
JIPO and WIN Join Forces to Promote Immunotherapy and Precision Oncology in 2022
Posted: Monday, January 10, 2022
![WIN SPRING 2021 Newsletter WIN SPRING 2021 Newsletter logotype](http://winconsortium.org/img/_people/WIN_Logo_05_200.png)
WIN SPRING 2021 Newsletter
Posted: Thursday, May 20, 2021
![Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival logotype](http://winconsortium.org/img/_people/Genome.png)
Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival
Posted: Friday, April 30, 2021
![WIN’s Digital Display Precision Predictor biomarker to guide cancer targeted therapy WIN’s Digital Display Precision Predictor biomarker to guide cancer targeted therapy logotype](http://winconsortium.org/img/_people/EIN_Presswire_%282%29.png)
WIN’s Digital Display Precision Predictor biomarker to guide cancer targeted therapy
Posted: Friday, April 30, 2021
![Behind the Paper: Digital Display Precision Predictor: the prototype of a global biomarker model Behind the Paper: Digital Display Precision Predictor: the prototype of a global biomarker model logotype](http://winconsortium.org/img/_people/Cancer_Community_%283%29.png)
Behind the Paper: Digital Display Precision Predictor: the prototype of a global biomarker model
Posted: Friday, April 30, 2021
![Gustave Roussy Joins the Worldwide Innovative Network (WIN) in Personalized Cancer Medicine Gustave Roussy Joins the Worldwide Innovative Network (WIN) in Personalized Cancer Medicine logotype](http://winconsortium.org/img/_people/EIN_Presswire_%282%29.png)
Gustave Roussy Joins the Worldwide Innovative Network (WIN) in Personalized Cancer Medicine
Posted: Thursday, April 29, 2021
![Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments logotype](http://winconsortium.org/img/_people/N_P_J_%283%29.png)
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments
Posted: Wednesday, April 28, 2021
![A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy logotype](http://winconsortium.org/img/_people/AACR_%282%29.png)
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy
Posted: Monday, September 09, 2019
![La Fondation ARC pour la recherche sur le cancer poursuit son engagement dans le développement La Fondation ARC pour la recherche sur le cancer poursuit son engagement dans le développement logotype](http://winconsortium.org/img/_people/Fondation-ARC-cancer-LogoFC.png)
La Fondation ARC pour la recherche sur le cancer poursuit son engagement dans le développement
Posted: Monday, July 08, 2019